Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

636 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of REG4 expression on chemoresistance of ovarian cancer.
Xiang LW, Xue H, Ha MW, Yu DY, Xiao LJ, Zheng HC. Xiang LW, et al. Among authors: yu dy. J Obstet Gynaecol. 2022 Oct;42(7):3149-3157. doi: 10.1080/01443615.2022.2106834. Epub 2022 Aug 5. J Obstet Gynaecol. 2022. PMID: 35929918 Free article.
Correction to: Indirect Treatment Comparisons in Healthcare Decision Making: A Targeted Review of Regulatory Approval, Reimbursement, and Pricing Recommendations Globally for Oncology Drugs in 2021-2023.
Igarashi A, Tanaka S, De Moor R, Li N, Hirozane M, Wu DB, Hong LW, Yu DY, Hashim M, Hutton B, Tantakoun K, Olsen C, Fashami FM, Samjoo IA, Cameron C. Igarashi A, et al. Among authors: yu dy. Adv Ther. 2025 Jan 6. doi: 10.1007/s12325-024-03087-2. Online ahead of print. Adv Ther. 2025. PMID: 39760977 No abstract available.
636 results